These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitor. Li X; Du Y; Du Y; Huang X J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):25-30. PubMed ID: 12652327 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme (rs4646994) and α ADDUCIN (rs4961) gene polymorphisms' study in primary spontaneous intracerebral hemorrhage. Kalita J; Misra UK; Bindu IS; Kumar B; Mittal B Neurol India; 2011; 59(1):41-6. PubMed ID: 21339657 [TBL] [Abstract][Full Text] [Related]
24. New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy. Batlle D; Soler MJ; Wysocki J Curr Opin Nephrol Hypertens; 2008 May; 17(3):250-7. PubMed ID: 18408475 [TBL] [Abstract][Full Text] [Related]
25. The relation of angiotensin-converting enzyme to the pregnancy-induced hypertension-preeclampsia syndrome. Goldkrand JW; Fuentes AM Am J Obstet Gynecol; 1986 Apr; 154(4):792-800. PubMed ID: 3008558 [TBL] [Abstract][Full Text] [Related]
26. Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1-Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy. Kolovou V; Lagou E; Mihas C; Vasiliki G; Katsiki N; Kollia A; Triposkiadis F; Degiannis D; Mavrogeni S; Kolovou G Open Cardiovasc Med J; 2015; 9():118-26. PubMed ID: 27006715 [TBL] [Abstract][Full Text] [Related]
27. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish hypertensive patients. Gunes HV; Ata N; Degirmenci I; Basaran A; Timuralp B; Dikmen M; Ustuner C; Kudaiberdieva G Int J Clin Pract; 2004 Sep; 58(9):838-43. PubMed ID: 15529517 [TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions. A twin study. Busjahn A; Knoblauch H; Knoblauch M; Bohlender J; Menz M; Faulhaber HD; Becker A; Schuster H; Luft FC Hypertension; 1997 Jan; 29(1 Pt 2):165-70. PubMed ID: 9039097 [TBL] [Abstract][Full Text] [Related]
32. Clinical variables, not RAAS polymorphisms, predict blood pressure response to ACE inhibitors in Sardinians. Filigheddu F; Argiolas G; Bulla E; Troffa C; Bulla P; Fadda S; Zaninello R; Degortes S; Frau F; Pitzoi S; Glorioso N Pharmacogenomics; 2008 Oct; 9(10):1419-27. PubMed ID: 18855530 [TBL] [Abstract][Full Text] [Related]
33. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Kiema TR; Kauma H; Rantala AO; Lilja M; Reunanen A; Kesäniemi YA; Savolainen MJ Hypertension; 1996 Dec; 28(6):1070-5. PubMed ID: 8952598 [TBL] [Abstract][Full Text] [Related]
34. Hemodynamic effects of angiotensin-converting enzyme inhibitors in essential hypertension: a review. Fitzpatrick MA; Julius S J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S35-9. PubMed ID: 2580174 [TBL] [Abstract][Full Text] [Related]
35. The emerging role of angiotensin-converting enzyme-2 in the kidney. Burns KD Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686 [TBL] [Abstract][Full Text] [Related]
36. Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes? Komers R; Anderson S Curr Opin Nephrol Hypertens; 2000 Mar; 9(2):173-9. PubMed ID: 10757223 [TBL] [Abstract][Full Text] [Related]
37. Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Tsai CT; Fallin D; Chiang FT; Hwang JJ; Lai LP; Hsu KL; Tseng CD; Liau CS; Tseng YZ Hypertension; 2003 Jan; 41(1):9-15. PubMed ID: 12511523 [TBL] [Abstract][Full Text] [Related]
38. The effect of angiotensin converting enzyme inhibition on effective renal plasma flow in patients with diffuse renal parenchymal diseases and hypertension. Zeravica R; Stosić Z; Ilincić B; Crnobrnja V; Jakovljević A; Mijović R Med Pregl; 2014; 67(3-4):78-82. PubMed ID: 24961048 [TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Wang JG; Staessen JA Eur J Pharmacol; 2000 Dec; 410(2-3):289-302. PubMed ID: 11134677 [TBL] [Abstract][Full Text] [Related]
40. Effects of angiotensin-converting enzyme inhibitors and sclerotherapy on portal hemodynamics in patients with portal hypertension. Nasr AA; el-Hak NG; Settein ME; Khafagy MA; Tadros MT Hepatogastroenterology; 2000; 47(33):795-806. PubMed ID: 10919035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]